Esophageal Cancer Information Center
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Esophageal Cancer Information Center has current, evidence-based information for you. Get the facts about esophageal cancer early detection, treatment, and survivorship, and stay up to date with ongoing esophageal cancer research that could impact your treatment decisions through our daily cancer news.
You are not alone—The CancerConnect Esophageal Cancer Community is the leading Social Media Application for Esophageal Cancer patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.
Accurate alternative to more costly, invasive endoscopy AMG 337 MET Inhibitor Produces Impressive, Rapid Response in Gastric and Esophageal Cancers
AMG 337 is a highly selective inhibitor of several forms of MET Esophageal Cancer Survival Improved Using Targeted Therapy Developed in Lung Cancer
Researchers reported that the Iressa® treated patients had improved survival by up to six months, and sometimes beyond
Cancer and its treatment can come with a variety of complications, some more serious... Advanced Directives
Living Wills Every competent adult has, in most cases, the freedom to accept or refuse... Caregivers
What is Caregiving and Who are Caregivers? Caregivers are individuals who provide...
Esophageal Cancer Management
Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the... Moving Bodies, Changing Lives
Moving On Aerobics helps women regain joy of movement and physical fitness after... Where Kids Can Be Kids… And Cancer Takes a Back Seat
Cancer camps for kids provide fun and camaraderie for children facing down a cancer...
Esophageal Cancer Clinical Trials
COGARAR0331 – Treatment of Childhood Nasopharyngeal Carcinoma with Neoadjuvant Chemotherapy and Concomitant Chemoradiotherapy Lip, Oral Cavity and Pharynx
GI-57 – Phase I/II Trial of Preoperative Oxaliplatin, Docetaxel, and Capecitabine with Concurrent Radiation Therapy in Localized Carcinoma of the Esophagus or Gastroesophageal Junction.
RTOG0436 – A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients with Esophageal Cancer Who Are Treated without Surgery